The PE Ratio as of September 2024 (TTM) for Applied DNA Sciences, Inc. (APDN) is -0.18

According to Applied DNA Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.18. This represents a change of -75.80% compared to the average of -0.74 of the last 4 quarters.

Applied DNA Sciences, Inc. (APDN) Historical PE Ratio (quarterly & annually)

How has APDN PE Ratio performed in the past?

The mean historical PE Ratio of Applied DNA Sciences, Inc. over the last ten years is -3.76. The current -0.18 PE Ratio has changed 378.17% with respect to the historical average. Over the past ten years (40 quarters), APDN's PE Ratio was at its highest in in the March 2023 quarter at 6.20. The PE Ratio was at its lowest in in the September 2015 quarter at -55.44.

Applied DNA Sciences, Inc. (APDN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Applied DNA Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied DNA Sciences, Inc. (APDN) Average PE Ratio

How has APDN PE Ratio performed in the past?

The current PE Ratio of Applied DNA Sciences, Inc. (APDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Applied DNA Sciences, Inc. (APDN) PE Ratio vs. Peers

How is APDN’s PE Ratio compared to its peers?

Applied DNA Sciences, Inc.’s PE Ratio is greater than Biodesix, Inc. (-4.97), greater than DarioHealth Corp. (-6.66), greater than Olink Holding AB (publ) (-96.25), greater than Genetron Holdings Limited (-0.63), greater than Exagen Inc. (-2.98), greater than Burning Rock Biotech Limited (-0.45), greater than Neuronetics, Inc. (-0.87), greater than Sera Prognostics, Inc. (-8.18), greater than OncoCyte Corporation (-1.05), greater than Personalis, Inc. (-3.55), less than Interpace Biosciences, Inc. (2.46), greater than iSpecimen Inc. (-6.14), greater than Trinity Biotech plc (-0.64), greater than Mainz Biomed B.V. (-0.20), greater than Prenetics Global Limited (-0.88), less than FONAR Corporation (7.08),

Build a custom stock screener for Applied DNA Sciences, Inc. (APDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied DNA Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied DNA Sciences, Inc. (APDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied DNA Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.